Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Fate Therapeutics (FATE) Debt Ratio (2016 - 2019)

Fate Therapeutics' Debt Ratio history spans 8 years, with the latest figure at 0.04 for Q3 2019.

  • For Q3 2019, Debt Ratio fell 39.4% year-over-year to 0.04; the TTM value through Sep 2019 reached 0.04, down 39.4%, while the annual FY2018 figure was 0.07, 50.32% down from the prior year.
  • Debt Ratio reached 0.04 in Q3 2019 per FATE's latest filing, down from 0.07 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.44 in Q1 2015 to a low of 0.04 in Q3 2019.
  • Average Debt Ratio over 5 years is 0.18, with a median of 0.16 recorded in 2018.
  • Peak YoY movement for Debt Ratio: skyrocketed 1670.23% in 2015, then plummeted 69.47% in 2017.
  • A 5-year view of Debt Ratio shows it stood at 0.27 in 2015, then crashed by 58.1% to 0.11 in 2016, then grew by 25.07% to 0.14 in 2017, then plummeted by 50.32% to 0.07 in 2018, then crashed by 41.39% to 0.04 in 2019.
  • Per Business Quant, the three most recent readings for FATE's Debt Ratio are 0.04 (Q3 2019), 0.07 (Q2 2019), and 0.07 (Q1 2019).